Iran Launches Production Line of Two Drugs for MS
TEHRAN (ISNA) – Iran has inaugurated the production line of two drugs for Multiple Sclerosis (MS) patients.
The production line of these two drugs was inaugurated in the presence of the Iranian First Vice-President, health minister, Vice-President for science and technology and minister of industry, mining and trade.
In this production line, Iran will produce Ziferon and Tebazio (teriflunomide) drugs for MS patients.
Tebazzio (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS). It is the active metabolite of leflunomide. Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for MS.
Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances.
The production line of these two drugs was inaugurated in the presence of the Iranian First Vice-President, health minister, Vice-President for science and technology and minister of industry, mining and trade.
In this production line, Iran will produce Ziferon and Tebazio (teriflunomide) drugs for MS patients.
Tebazzio (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS). It is the active metabolite of leflunomide. Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for MS.
Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances.